COMMUNIQUÉS West-GlobeNewswire

Trading by management and close relations of management
14/05/2018
Read the full announcement in the attached file Attachment 2018_30_Trading_by_management_EN
Share buy-back week 19/2018
14/05/2018
Announcement 14 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]
ChromaDex Appoints Nobel Laureate, Professor Sir John Walker, to the Scientific Advisory Board
14/05/2018
World-Renowned British Chemist to Assist in Uncovering New Applications for Nicotinamide Riboside and Mitochondrial Health IRVINE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated [...]
Evoke Pharma Reports First Quarter 2018 Results and Highlights
14/05/2018
The Company will hold a conference call following submission of Gimoti NDA NDA submission for Gimoti™ on track for second quarter of 2018 Announced discovery of sex-based pharmacokinetic differences for Gimoti Waiver of [...]
Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in May and June
14/05/2018
Press Release 14 May 2018 Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in May and June Immunicum AB (publ; IMMU.ST) today announced that Company leadership will present the [...]
Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch Clinical Study
14/05/2018
IRB Approval Signals ‘Green Light’ for Sernova’s Clinical Protocol to Proceed LONDON, Ontario, May 14, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V: SVA ) (OTCQB:SEOVF) (FSE:PSH), announces today it has received [...]
OraSure Technologies to Present at the UBS Global Healthcare Conference
14/05/2018
BETHLEHEM, Pa., May 14, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President [...]
Healthwise Recognized for Plain-Language Excellence With 2018 Grand ClearMark Award
14/05/2018
BOISE, Idaho, May 14, 2018 (GLOBE NEWSWIRE) -- When people get health information they understand, they can make better health decisions. For over 40 years Healthwise has written clear and simple health education that [...]
Fennec Provides Business Update and Announces First Quarter 2018 Financial Results
14/05/2018
PEDMARK TM granted Breakthrough Therapy and Fast Track Designations by FDA Actively preparing for NDA submission later this year Strong financial position with $26.7 million in cash and no debt RESEARCH TRIANGLE PARK, N [...]
Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection
14/05/2018
RANCHO CUCAMONGA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that the U.S. Food and Drug Administration (“FDA”) granted approval of the company’s abbreviated new [...]
International Endeavors Corporation, a Medical Marijuana IP Holdings Company, Secures a $500,000 Investment Commitment From Voltage River
14/05/2018
TEMECULA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation, a Medical Marijuana IP Holdings Company, today announces that the Company has received an investment commitment of [...]
Invitation: Terveystalo result audiocast and conference call on 16 May 2018
14/05/2018
Terveystalo Plc will publish its Interim report for January-March 2018 on 16 May 2018 at approximately 9:00 a.m. EEST (Finnish time). The company will hold an audiocast and conference call in English at 12:30 EEST ( [...]
Xbrane Biopharma and Episurf invites to a company presentation in Stockholm May 29
14/05/2018
Press release 2018-05-14 Xbrane Biopharma and Episurf Medical invites to a company presentation held at Episurf Medical's office at Karlavägen 60 in Stockholm on May 29, 18.00-20.30 CEST. Xbrane Biopharma will be [...]
Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
14/05/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period Paris, France and [...]
mise à jour: Sanofi et Ablynx annoncent le succès des offres publiques d'acquisition sur Ablynx et le lancement d'offres de reprise
14/05/2018
Il sagit dune mise à jour du communiqué 08:00 14.05.2018 CEST. Explication de la mise à jour; mauvais logo. Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Ablynx annoncent le succès des [...]
Xbrane Biopharma releases interim report for the first quarter of 2018
14/05/2018
Press release 2018-05-14 Xbrane Biopharma AB's (publ.) ("Xbrane") interim report for the first quarter of 2018 is now available on the Company's website, www.xbrane.com . Financial summary first quarter 201 8 Revenues [...]
Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
14/05/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period Paris, France and [...]
Sanofi et Ablynx annoncent le succès des offres publiques d'acquisition sur Ablynx et le lancement d'offres de reprise
14/05/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Ablynx annoncent le succès des offres publiques d'acquisition sur Ablynx et le lancement d'offres de reprise Paris, France et Gand, Belgique - [...]
SANOFI AND ABLYNX ANNOUNCE THE SUCCESSFUL RESULTS OF THE INITIAL TENDER OFFER PERIOD FOR ABLYNX AND COMMENCEMENT OF SQUEEZE-OUT TENDER PERIOD
14/05/2018
Paris, France and Ghent, Belgium - May 14, 2018 - Sanofi [Euronext: SAN; NYSE: SNY] and Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced the results of the initial tender offer period of Sanofi's previously [...]

Pages